PR Newswire
AUSTIN, Texas, April 26, 2017
AUSTIN, Texas, April 26, 2017 /PRNewswire/ -- Luminex
Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference
on Wednesday, May 3, 2017 at 10:00am ET in Boston, Massachusetts.
The investor presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address
above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to
the event to register, download and install any necessary audio/video software. If you are unable to participate during the live
webcast, the presentation will be archived for six months on the website using the 'replay' link.
ABOUT LUMINEX CORPORATION
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing
health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical
drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable
answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit
us at www.luminexcorp.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/luminex-corporation-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-300445467.html
SOURCE Luminex Corporation